| scholarly article | Q13442814 |
| P2093 | author name string | N Wagner | |
| F Tacke | |||
| A Schippers | |||
| K Tenbrock | |||
| T Ostendorf | |||
| A Wiener | |||
| K Ohl | |||
| N Honke | |||
| P2860 | cites work | A chemokine-driven positive feedback loop organizes lymphoid follicles | Q28142202 |
| A putative chemokine receptor, BLR1, directs B cell migration to defined lymphoid organs and specific anatomic compartments of the spleen | Q28300225 | ||
| Follicular helper CD4 T cells (TFH) | Q29615063 | ||
| IL-2 protects lupus-prone mice from multiple end-organ damage by limiting CD4-CD8- IL-17-producing T cells | Q34053939 | ||
| T cells as therapeutic targets in SLE. | Q34075552 | ||
| Ectopic lymphoid organogenesis: a fast track for autoimmunity | Q34363840 | ||
| Inhibition of aberrant circulating Tfh cell proportions by corticosteroids in patients with systemic lupus erythematosus | Q34532672 | ||
| Lpr and gld: single gene models of systemic autoimmunity and lymphoproliferative disease | Q34602392 | ||
| Expanded double negative T cells in patients with systemic lupus erythematosus produce IL-17 and infiltrate the kidneys | Q34892862 | ||
| CD4(-)CD8(-) T-cells in primary Sjögren's syndrome: association with the extent of glandular involvement | Q35086094 | ||
| Characterization of a novel and spontaneous mouse model of inflammatory arthritis | Q35617627 | ||
| Pathogenetic role of glomerular CXCL13 expression in lupus nephritis. | Q51723759 | ||
| Systemic lupus erythematosus. | Q53202066 | ||
| Serum BLC/CXCL13 concentrations and renal expression of CXCL13/CXCR5 in patients with systemic lupus erythematosus and lupus nephritis. | Q53356773 | ||
| Circulating CXCR5+CD4+helper T cells in systemic lupus erythematosus patients share phenotypic properties with germinal center follicular helper T cells and promote antibody production. | Q53618640 | ||
| Increased serum levels of soluble L-selectin (CD62L) in patients with active systemic lupus erythematosus (SLE) | Q56907703 | ||
| Expansion of circulating T cells resembling follicular helper T cells is a fixed phenotype that identifies a subset of severe systemic lupus erythematosus | Q61411628 | ||
| Identification of a previously unknown antigen-specific regulatory T cell and its mechanism of suppression | Q73977252 | ||
| Analysis and classification of B-cell infiltrates in lupus and ANCA-associated nephritis | Q81402177 | ||
| Aberrant high expression of B lymphocyte chemokine (BLC/CXCL13) by C11b+CD11c+ dendritic cells in murine lupus and preferential chemotaxis of B1 cells towards BLC | Q95721431 | ||
| Double negative regulatory T cells in transplantation and autoimmunity: recent progress and future directions | Q35716736 | ||
| Mechanisms of B cell autoimmunity in SLE. | Q35840704 | ||
| Programmed cell death 1 and Helios distinguish TCR-αβ+ double-negative (CD4-CD8-) T cells that derive from self-reactive CD8 T cells | Q35856318 | ||
| Regulation of inherently autoreactive VH4-34 B cells in the maintenance of human B cell tolerance | Q36041818 | ||
| cAMP-responsive element modulator α (CREMα) trans-represses the transmembrane glycoprotein CD8 and contributes to the generation of CD3+CD4-CD8- T cells in health and disease | Q37272180 | ||
| The role of IL-23/IL-17 axis in lupus nephritis | Q37397437 | ||
| cAMP responsive element modulator (CREM) α mediates chromatin remodeling of CD8 during the generation of CD3+ CD4- CD8- T cells | Q37511786 | ||
| B-cell depletion in the treatment of lupus nephritis | Q38026784 | ||
| CXCL13 as a new biomarker of systemic lupus erythematosus and lupus nephritis - from bench to bedside? | Q38241317 | ||
| Interleukin-2 treatment reverses effects of cAMP-responsive element modulator α-over-expressing T cells in autoimmune-prone mice | Q41147908 | ||
| T cell receptor alpha/beta expressing double-negative (CD4-/CD8-) and CD4+ T helper cells in humans augment the production of pathogenic anti-DNA autoantibodies associated with lupus nephritis | Q44381577 | ||
| P275 | copyright license | Creative Commons Attribution-NonCommercial 4.0 International | Q34179348 |
| P6216 | copyright status | copyrighted | Q50423863 |
| P433 | issue | 1 | |
| P407 | language of work or name | English | Q1860 |
| P304 | page(s) | 22-32 | |
| P577 | publication date | 2016-03-14 | |
| P1433 | published in | Clinical and Experimental Immunology | Q15716708 |
| P1476 | title | CXCR5 is critically involved in progression of lupus through regulation of B cell and double-negative T cell trafficking | |
| P478 | volume | 185 |
| Q55266643 | CD11c-Specific Deletion Reveals CREB as a Critical Regulator of DC Function during the Germinal Center Response. |
| Q26741199 | Chemokines and Chemokine Receptors in the Development of Lupus Nephritis |
| Q39218839 | Research and therapeutics-traditional and emerging therapies in systemic lupus erythematosus |
| Q47136733 | Stabilized β-Catenin Ameliorates ALPS-Like Symptoms of B6/lpr Mice |
| Q39609044 | TCF1 deficiency ameliorates autoimmune lymphoproliferative syndrome (ALPS)-like phenotypes of lpr/lpr mice. |
| Q47095273 | The correlational research among serum CXCL13 levels, circulating plasmablasts and memory B cells in patients with systemic lupus erythematosus: A STROBE-compliant article |
Search more.